1. India Stocks

  2. •

    Health technology

  3. •

    Pharmaceuticals: other
Transchem Limited

Transchem Limited

BBSE:TRANSCHEM
418.00
INR
+1.00
(+0.24%)
5.74EPS
59.65P/E
4.19BMarket Cap
2014 Y
2015 Y
2016 Y
2017 Y
2018 Y
2019 Y
2020 Y
2021 Y
2022 Y
2023 Y
2024 Y
2025 Y
2026 Y
TTM
Revenue per Share
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
0.33
2.15
- -
- -
Basic EPS, GAAP
-0.66
0.1
0.04
-0.18
-0.97
0.25
0.33
19.73
2.34
1.01
3.43
4.27
3.51
5.74
Free Cash Flow per Basic Share
0.47
0.86
0.83
0.45
-16.17
8.44
-0.52
-22.71
17.9
1
-32.12
29.41
-1.3
- -
Dividend per Share
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
Book Value per Share
31.23
31.33
31.22
31.04
30.07
31.03
30.04
51.42
54.17
53.79
61.8
64.8
68.28
- -
Tangible Book Value per Share
31.23
31.33
31.22
31.04
30.07
31.03
30.04
51.42
54.17
53.79
61.8
64.8
68.28
- -
Basic Weighted Avg Shares
12
12
12
12
12
12
12
12
12
12
12
12
12
12
Sales/Revenue/Turnover
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
4
26
- -
- -
Operating Margin (%)
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
-419.71
-55.87
- -
- -
Depreciation Expense
15
11
10
10
10
8
6
1
- -
- -
- -
- -
- -
1
Net Income, GAAP
-8
1
- -
-2
-12
3
4
242
29
12
42
52
43
70
Effective Tax Rate (%)
- -
- -
- -
- -
- -
60.64
48.32
2.5
26.61
50.6
25.64
26.01
23.41
22.06
Profit Margin (%)
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
1,025.22
198.67
- -
- -
Working Capital
261
273
281
290
295
279
296
544
576
578
668
773
815
- -
LT Debt
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
Total Equity
382
383
382
380
368
380
368
629
663
658
756
793
836
- -
Return on Invested Capital (%)
- -
0.31
- -
- -
- -
-2.21
-2.71
39.89
-3.13
-1.3
-1.8
-0.93
-1.96
- -
Return on Capital (%)
- -
0.31
- -
- -
- -
0.82
1.1
48.44
4.44
1.87
5.94
6.74
5.27
- -
Return on Common Equity (%)
-2.08
0.31
0.12
-0.57
-3.18
0.82
1.1
48.44
4.44
1.87
5.94
6.74
5.27
- -

Capital Structure

INR

•

in mil. unless spec.
Dec'26
Mar'26
Jun'27
ST Debt
- -
- -
- -
LT Borrowings
- -
- -
- -
LT Finance Leases
- -
- -
- -
Preferred Equity and Hybrid Capital
- -
- -
- -
Shares Outstanding
12
12
12
Market Capitalization
2,241
1,991
4,187

Working Capital

INR

•

in mil. unless spec.
Dec'26
Mar'26
Jun'27
Total Current Assets
- -
855
- -
Cash, Cash Equivalents & STI
- -
427
- -
Accounts Receivable, Net
- -
22
- -
Inventories
- -
- -
- -
Total Current Liabilities
- -
40
- -
Payables & Accruals
- -
- -
- -
ST Debt
- -
- -
- -
Deferred Revenue
- -
- -
- -

Growth Rates

INR

•

in mil. unless spec.

(avg. rate of change)

10 years
5 years
1 year
Total Equity
9.72%
5.95%
5.37%
Free Cash Flow
-358.9%
-778.69%
-104.42%
Net Income, GAAP
568.27%
20.26%
-17.81%
Sales/Revenue/Turnover
- -
- -
-100%
Total Cash Common Dividend
- -
- -
- -

Quarterly Revenue

INR

•

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2025
- -
- -
2
24
26
2026
- -
- -
- -
- -
- -
2027
- -
- -
- -
- -
- -

Quarterly Earnings Per Share

INR

•

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2025
1.36
1.18
1.13
0.6
4.27
2026
0.81
- -
0.43
1.71
3.51
2027
2.79
- -
- -
- -
- -

Quarterly Dividends Per Share

INR

•

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2025
- -
- -
- -
- -
- -
2026
- -
- -
- -
- -
- -
2027
- -
- -
- -
- -
- -

Company Description

Company Profile APIChatGPT
CEO
Mahesh Suresh Rananavre
Full Time Employees
12
Sector
Health technology
Industry
Pharmaceuticals: other
Address
111, Maker Chambers IV, 11th Floor Thane MA India 400 021
IPO Date
Jan 27, 1993
Website
transchem.net
Similar Companies
Cipla Ltd (NSE:CIPLA)
Aurobindo Pharma Ltd (NSE:AUROPHARMA)
Lupin Limited (NSE:LUPIN)
Granules India Limited (NSE:GRANULES)
Revolution Medicines, Inc. (NASDAQ:RVMD)
Egyptian International Pharmaceutical Industries Co. (EGX:PHAR)
Business
Transchem Limited (BSE: TRANSCHEM.BO), a public limited company listed on the Bombay Stock Exchange, engages in trading agricultural goods with no significant current operations. Incorporated in 1976 as a private limited company and converted to public limited status in 1992, the company is headquartered at 111 Maker Chambers IV, 11th Floor, Nariman Point, Mumbai, India, with a registered office at 304 Ganatra Estate, Pokhran Road No. 1, Khopat, Thane, Maharashtra. Historically, Transchem dealt in chemicals and pharmaceuticals before diversifying into mushroom production and processing in 1993, operating a mushroom plant in Talegaon village, Taluka Maval, District Pune; the plant currently stands non-operational due to shifts in the international horticulture market. In October 2025, the company enters into a non-binding term sheet to acquire Greshma Shares & Stocks Limited for cash consideration, aiming for 100% ownership pending due diligence, definitive agreements, board and regulatory approvals, with expected completion within three months; Greshma reported revenue of INR 113.2 million and equity of INR 158.9 million as of March 31, 2025. Transchem operates primarily in India, focusing on agricultural trading segments without active manufacturing or processing facilities at present.